Local view for "http://purl.org/linkedpolitics/eu/plenary/2011-03-07-Speech-1-202-000"
| Predicate | Value (sorted: default) |
|---|---|
| rdf:type | |
| dcterms:Date | |
| dcterms:Is Part Of | |
| dcterms:Language | |
| lpv:document identification number |
"en.20110307.23.1-202-000"2
|
| lpv:hasSubsequent | |
| lpv:speaker | |
| lpv:spokenAs | |
| lpv:translated text |
"Member States and the European institutions have implemented a series of costly measures that were, in many cases, out of all proportion to the true severity of H1N1 influenza. In Europe, according to estimates by the European Centre for Disease Control and Prevention, H1N1 influenza caused about 2 900 deaths in 2009. These figures are significantly lower than official estimates of deaths caused by seasonal flu alone and stand as testimony to the moderate severity of this influenza virus.
I therefore urge that the greatest attention should be paid to this issue so that the World Health Organisation (WHO) can conduct a review to issue a new definition of the criteria used for issuing a global pandemic alert, which takes into account not only the geographical spread of the disease, but also of its virulence. In addition, an analysis of the H1N1 crisis management by the EU clearly reveals to me an emerging need for strengthening cooperation among health authorities of Member States and the European institutions.
Finally, since I believe that to ensure the success or failure of a trial, it is essential to conduct studies on vaccines and antiviral drugs that are independent of pharmaceutical companies, I fully agree with the rapporteur’s request to make public the names of all the experts who are consulted by the European public health authorities."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples